Tower Research Capital (TRC)’s BIND THERAPEUTICS INC BIND Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-300	Closed	-$1K	–	5739
2015 Q4	$1K	Buy	+300	New	+$1.21K	﹤0.01%	4347
2015 Q3	–	Sell	-700	Closed	-$4K	–	5605
2015 Q2	$4K	Buy	700 +487	+229%	+$3.02K	﹤0.01%	3496
2015 Q1	$2K	Buy	213 +150	+238%	+$922	﹤0.01%	3957
2014 Q4	$0	Sell	63 -905	-93%	-$6.79K	﹤0.01%	5510
2014 Q3	$8K	Buy	+968	New	+$9.54K	﹤0.01%	3048
2014 Q2	–	Sell	-408	Closed	-$5K	–	5381
2014 Q1	$5K	Buy	+408	New	+$5.33K	﹤0.01%	3378

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Tower Research Capital (TRC)'s BIND Position: Q1 2016 in Review

Tower Research Capital (TRC) sold out of BIND THERAPEUTICS INC (BIND) in Q1 2016, closing a stake of 300 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in BIND in Q1 2014 and held it in 6 quarters. The position peaked at $8K in Q3 2014. 34 funds tracked by Wall St. Rank hold BIND as of Q1 2016.

Tower Research Capital (TRC) reported no remaining BIND THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 300 BIND THERAPEUTICS INC shares in Q1 2016, an estimated $1K.
Tower Research Capital (TRC) first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 6 quarters.
Tower Research Capital (TRC)'s BIND THERAPEUTICS INC position peaked at $8K in Q3 2014.
34 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q1 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.